繁體版 簡體版
 
 
Investor News  
Home > News > Investor News
2010/03/25
SciVision Biotech Receives TFDA Approval for Hya-Dermis Facial Dermal Implant
 

SciVision Biotech Inc. today announced Taiwan Food and Drug Administration (TFDA) approval for Hya-Dermis Facial Dermal Implant, a novel hyaluronan-based dermal filler. It is being launched as the first MIT product in Taiwan aesthetics market.

Hya-Dermis, which is non animal-sourced product, is intended to inject intradermally for soft tissue augmentation. Hya-Dermis is proved safe and effective by a randomized, double-blinded, and controlled clinical trial.

Link:
File:
   
 
     
 
 
Investor News
Press Releases
Latest News